M. N. V. Ravi Kumar, Ph.D.

Distinguished Professor
University of Alabama

Poster(s):

• (W0930-05-28) Exploring the Effects of Nano-Enabled Oral Insulin and Anti-Inflammatory Agent in Mitigating Diabetic Ocular Complications in Type 2 Diabetic Rat Model
  Wednesday, November 12, 2025

  9:30 AM - 10:30 AM CT

• (W1030-06-36) Engineered Oral Nanoparticle Delivery for Metronomic Chemotherapy in a PTX-Resistant Ovarian Cancer Mouse Model: Investigating the Efficacy and Off-target Effects
  Wednesday, November 12, 2025

  10:30 AM - 11:30 AM CT

• (W1030-07-41) Effective Delivery of Cyclosporine Prevents Immune-Vascular Balance in Lupus in the MRL-lpr Mouse Model
  Wednesday, November 12, 2025

  10:30 AM - 11:30 AM CT

• (T1030-07-43) Cyclosporine A Nanoparticles Combined with Urolithin A Mitigate Osteoporosis in Ovariectomized MRL/lpr Mice
  Tuesday, November 11, 2025

  10:30 AM - 11:30 AM CT

• (T1130-06-35) Dual-Action Nanotherapy Reduces Ocular Inflammation in Mice with Systemic LPS-Induced Uveitis
  Tuesday, November 11, 2025

  11:30 AM - 12:30 PM CT

• (W1130-07-43) Urolithin-A Laden Nanoparticles Attenuate Cisplatin-Induced Systemic Toxicity: A Comparative Study in Aged and Young Mice
  Wednesday, November 12, 2025

  11:30 AM - 12:30 PM CT

• (T1130-09-60) Tailoring Polyester Topologies for Efficient Oral Drug Delivery Systems
  Tuesday, November 11, 2025

  11:30 AM - 12:30 PM CT

• (T1330-06-36) Urolithin A-Laden P2Ns-GA Enhances Anticancer Efficacy in Cisplatin-Resistant Ovarian Cancer and Mitigate Nephrotoxicity in a Murine Model
  Tuesday, November 11, 2025

  1:30 PM - 2:30 PM CT